These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 727149)

  • 1. Systemic and pulmonary hemodynamic effects of saralasin infusion in hypertension. Predictability of plasma renin status from hemodynamic changes.
    Mookherjee S; Obeid A; Warner R; Anderson G; Eich R; Smulyan H
    Am J Cardiol; 1978 Dec; 42(6):987-92. PubMed ID: 727149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in arterial oxygenation by saralasin infusion in man.
    Mookherjee S; Obeid AI; Ashutosh K; Warner RA; Smulyan H
    Chest; 1979 Apr; 75(4):492-4. PubMed ID: 36260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic correlates of saralasin-induced arterial pressure changes.
    de Carvalho JG; Dunn FG; Kem DC; Chrysant SG; Froholich ED
    Circulation; 1978 Feb; 57(2):373-8. PubMed ID: 618629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.
    Arroyo V; Bosch J; Mauri M; Ribera F; Navarro-López F; Rodés J
    Eur J Clin Invest; 1981 Jun; 11(3):221-9. PubMed ID: 6791942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial oxygenation and pulmonary function with Saralasin in chronic lung disease.
    Mookherjee S; Ashutosh K; Smulyan H; Vardan S; Warner R
    Chest; 1983 Jun; 83(6):842-7. PubMed ID: 6406162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic circulatory adjustments to acute hypoxia and reoxygenation in unanesthetized sheep. Role of renin, angiotensin II, and catecholamine interactions.
    Davidson D; Stalcup SA
    J Clin Invest; 1984 Feb; 73(2):317-28. PubMed ID: 6365971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic hemodynamic and hormonal responses during angiotensin II blockade with saralasin.
    Roos JC; Geyskes GG; Boer P; Dorhout Mees EJ
    J Cardiovasc Pharmacol; 1981; 3(5):1106-15. PubMed ID: 6168855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic effects of captopril in hypertensive patients: comparison with saralasin.
    Fagard R; Amery A; Lijnen P; Reybrouck T
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():131s-134s. PubMed ID: 396066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamic changes after angiotensin II blockade by saralasin (author's transl)].
    Liebau G; Beyer J; Larbig D; Schick K; Sekanina G; Hayduk K
    Klin Wochenschr; 1977 Jul; 55(13):647-9. PubMed ID: 19645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II blockade in congestive heart failure.
    Turini GA; Brunner HR; Ferguson RK; Rivier JL; Gavras H
    Arch Int Pharmacodyn Ther; 1978 May; 233(1):166-76. PubMed ID: 686905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic effects of sar1-ala8-angiotensin in patients with renovascular hypertension (author's transl)].
    Philipp T; Zschierdrich H; Distler A
    Klin Wochenschr; 1977 Sep; 55(18):917-9. PubMed ID: 916618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic correlates of saralasin: responsiveness in hypertension.
    Kem DC; Frohlich ED; de Carvalho JG; Dunn FG; Chrysant SG; Danisa K; Wambach G
    Kidney Int Suppl; 1979 Mar; (9):S68-74. PubMed ID: 289866
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of the angiotensin antagonist saralasin on hemodynamics in hypertensive non-uraemic chronic renal disease.
    Brod J; Bahlmann J; Cachovan M; Hubrich W; Pretschner D
    Nephron; 1980; 25(4):167-72. PubMed ID: 6990284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 1-Sar-8-Ala-angiotensin II on systemic and pulmonary haemodynamics in hypertensive patients.
    Fagard R; Amery A; Lijnen P; Reybrouck T; Joossens JV; Billiet L; Moerman E; De Schaepdryver A
    Clin Exp Pharmacol Physiol; 1978; 5(5):457-64. PubMed ID: 729204
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of the converting enzyme inhibitor (SQ 20881) on the pulmonary circulation in man.
    Niarchos AP; Roberts AJ; Laragh JH
    Am J Med; 1979 Nov; 67(5):785-91. PubMed ID: 315711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic effects of Sar1-Ala8-angiotensin II in patients with renovascular hypertension.
    Fagard R; Amery A; Ljnen P; Reybrouck T; Billiet L
    Prog Biochem Pharmacol; 1976; 12():242-9. PubMed ID: 1019167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension.
    Gavras H; Flessas A; Ryan TJ; Brunner HR; Faxon DP; Gavras I
    JAMA; 1977 Aug; 238(8):880-2. PubMed ID: 577978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.
    Anderson GH; Streeten DH; Dalakos TG
    Circ Res; 1977 Mar; 40(3):243-50. PubMed ID: 837471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of captopril in patients with severe chronic heart failure.
    LeJemtel TH; Keung E; Frishman WH; Ribner HS; Sonnenblick EH
    Am J Cardiol; 1982 Apr; 49(6):1484-8. PubMed ID: 7041587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.